Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 179,400 | 203,700 | 285,300 | 150,800 | 187,300 |
| Receivables | 1,079,800 | 1,101,900 | 1,206,200 | 1,316,200 | 1,139,500 |
| Inventories | 2,173,800 | 2,047,600 | 2,279,000 | 2,230,500 | 2,250,600 |
| Other current assets | 458,900 | 427,700 | 449,400 | 444,700 | 443,700 |
| TOTAL | $3,891,900 | $3,780,900 | $4,219,900 | $4,142,200 | $4,021,100 |
| Non-Current Assets | |||||
| PPE Net | 1,701,200 | 1,698,200 | 1,938,700 | 1,949,100 | 1,940,700 |
| Investments And Advances | 200,800 | 110,000 | 182,400 | 183,100 | 182,700 |
| Intangibles | 8,153,000 | 8,063,200 | 8,430,200 | 8,460,800 | 8,406,800 |
| Other Non-Current Assets | 217,600 | 304,600 | 283,400 | 273,000 | 165,300 |
| TOTAL | $10,272,600 | $10,176,000 | $10,834,700 | $10,866,000 | $10,695,500 |
| Total Assets | $14,164,500 | $13,956,900 | $15,054,600 | $15,008,200 | $14,716,600 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 676,500 | 200,000 | 200,100 | 200,100 | 100 |
| Accounts payable and accrued liabilities | 445,500 | 468,900 | 449,300 | 460,700 | 458,300 |
| Accrued Expenses | 587,400 | N/A | 901,700 | 767,800 | 703,500 |
| Other current liabilities | N/A | 1,194,000 | N/A | N/A | N/A |
| TOTAL | $2,496,800 | $2,093,900 | $2,693,800 | $2,496,300 | $2,247,700 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,569,600 | 3,942,700 | 4,659,900 | 4,861,500 | 5,244,200 |
| Other Non-Current Liabilities | 1,212,000 | 1,218,300 | 1,274,099 | 1,217,700 | 1,207,500 |
| TOTAL | $5,784,200 | $6,177,500 | $7,047,699 | $7,390,200 | $7,647,400 |
| Total Liabilities | $8,281,000 | $8,271,400 | $9,741,500 | $9,886,500 | $9,895,100 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 153,688 | 154,031 | 153,814 | 153,173 | 152,757 |
| Common Shares | 734,000 | 734,000 | 734,000 | 734,000 | 734,000 |
| Retained earnings | 7,054,600 | 6,999,300 | 6,797,700 | 6,719,700 | 6,548,800 |
| Other shareholders' equity | 475,800 | 354,900 | 194,500 | 125,900 | 28,600 |
| TOTAL | $5,883,500 | $5,685,500 | $5,313,100 | $5,121,700 | $4,821,500 |
| Total Liabilities And Equity | $14,164,500 | $13,956,900 | $15,054,600 | $15,008,200 | $14,716,600 |